Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis

被引：0
|
作者：
Tadashi Namisaki
Kosuke Kaji
Naotaka Shimozato
Daisuke Kaya
Takahiro Ozutsumi
Yuki Tsuji
Yukihisa Fujinaga
Koh Kitagawa
Masanori Furukawa
Shinya Sato
Yasuhiko Sawada
Norihisa Nishimura
Hiroaki Takaya
Yasushi Okura
Kenichiro Seki
Hideto Kawaratani
Kei Moriya
Ryuichi Noguchi
Kiyoshi Asada
Takemi Akahane
Akira Mitoro
Hitoshi Yoshiji
机构：
[1] Nara Medical University,Department of Gastroenterology
来源：
Indian Journal of Gastroenterology | 2022年 / 41卷
关键词：
Angiotensin II receptor blocker; Farnesoid X receptor; Hepatic regression; Hepatic stellate cell; Lipopolysaccharide; Liver fibrosis; Losartan; Nonalcoholic steatohepatitis; Obeticholic acid; TGF beta; Toll-like receptor 4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：169 / 180
页数：11
相关论文
共 50 条
  • [1] Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis
    Namisaki, Tadashi
    Kaji, Kosuke
    Shimozato, Naotaka
    Kaya, Daisuke
    Ozutsumi, Takahiro
    Tsuji, Yuki
    Fujinaga, Yukihisa
    Kitagawa, Koh
    Furukawa, Masanori
    Sato, Shinya
    Sawada, Yasuhiko
    Nishimura, Norihisa
    Takaya, Hiroaki
    Okura, Yasushi
    Seki, Kenichiro
    Kawaratani, Hideto
    Moriya, Kei
    Noguchi, Ryuichi
    Asada, Kiyoshi
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (02) : 169 - 180
  • [2] Effect of Combined Farnesoid X Receptor Agonist and Angiotensin II Type 1 Receptor Blocker on Hepatic Fibrosis
    Namisaki, Tadashi
    Moriya, Kei
    Kitade, Mitsuteru
    Takeda, Kosuke
    Kaji, Kosuke
    Okura, Yasushi
    Shimozato, Naotaka
    Sato, Shinya
    Nishimura, Norihisa
    Seki, Kenichiro
    Kawaratani, Hideto
    Takaya, Hiroaki
    Sawada, Yasuhiko
    Akahane, Takemi
    Saikawa, Soichiro
    Nakanishi, Keisuke
    Kubo, Takuya
    Furukawa, Masanori
    Noguchi, Ryuichi
    Asada, Kiyoshi
    Kitagawa, Koh
    Ozutsumi, Takahiro
    Tsuji, Yuki
    Kaya, Daisuke
    Fujinaga, Yukihisa
    Yoshiji, Hitoshi
    HEPATOLOGY COMMUNICATIONS, 2017, 1 (09) : 928 - 945
  • [3] Effect of combined farnesoid X receptor agonist and angiotensin 2 receptor blocker on established liver fibrosis in rats
    Namisaki, Tadashi
    Kaji, Kosuke
    Nakanishi, Keisuke
    Tsuji, Yuki
    Sato, Shinya
    Sawada, Yasuhiko
    Akahane, Takemi
    Furukawa, Masanori
    Fujinaga, Yukihisa
    Takaya, Hiroaki
    Yoshiji, Hitoshi
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E542 - E542
  • [4] ANTIFIBROTIC EFFECTS OF COMBINED TREATMENT WITH FARNESOID X RECEPTOR AGONIST AND ANGIOTENSIN-II TYPE1 RECEPTOR BLOCKER ON HEPATIC FIBROGENESIS IN THE RAT MODEL OF NONALCOHOLIC STEATOHEPATITIS
    Namisaki, T.
    Okura, Y.
    Sato, S.
    Noguchi, R.
    Moriya, K.
    Kitade, M.
    Takeda, K.
    Nishimura, N.
    Sawada, Y.
    Seki, K.
    Kawaratani, H.
    Kaji, K.
    Yoshiji, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S686 - S686
  • [5] Impact of the combination of Farnesoid X receptor agonist and angiotensin-II type1 receptor blocker on hepatic fibrogenesis in the rat model of nonalcoholic steatohepatitis
    Namisaki, Tadashi
    Okura, Yasushi
    Sato, Shinya
    Kitade, Mitsuteru
    Kaji, Kosuke
    Nishimura, Norihisa
    Moriya, Kei
    Takeda, Kosuke
    Seki, Kenichiro
    Shimozato, Naotaka
    Noguchi, Ryuichi
    Kawaratani, Hideto
    Sawada, Yasuhiko
    Yoshiji, Hitoshi
    HEPATOLOGY, 2016, 64 : 828A - 828A
  • [6] Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosis
    Shimozato, Naotaka
    Namisaki, Tadashi
    Kaji, Kosuke
    Kitade, Mitsuteru
    Okura, Yasushi
    Sato, Shinya
    Moriya, Kei
    Seki, Kenichiro
    Kawaratani, Hideto
    Takaya, Hiroaki
    Sawada, Yasuhiko
    Saikawa, Soichiro
    Nakanishi, Keisuke
    Furukawa, Masanori
    Fujinaga, Yukihisa
    Kubo, Takuya
    Asada, Kiyoshi
    Kitagawa, Koh
    Tsuji, Yuki
    Kaya, Daisuke
    Ozutsumi, Takahiro
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    HEPATOLOGY RESEARCH, 2019, 49 (10) : 1147 - 1161
  • [7] Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor Blocker
    Bakris, George L.
    JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (01): : 27 - 32
  • [8] Angiotensin II type 1 receptor blocker combined with hydrochlorothiazide for the treatment of hypertension
    Miura, Shin-ichiro
    Saku, Keijiro
    INTERNAL MEDICINE, 2008, 47 (13) : 1163 - 1164
  • [9] Angiotensin II induces TGF-β1 mRNA in rat hepatic stellate cells:: The potential therapeutic effect of angiotensin II type 1 receptor blocker for hepatic fibrosis.
    Kamada, Y
    Tamura, S
    Kiso, S
    Fukui, K
    Doi, Y
    Ito, N
    Terui, Y
    Saito, T
    Watanabe, H
    Togashi, H
    Kawata, S
    Matsuzawa, Y
    HEPATOLOGY, 2001, 34 (04) : 400A - 400A
  • [10] Effect of an Angiotensin-II Type-1 Receptor Blocker, Candesartan on Hepatic Fibrosis in Chronic Hepatitis C: A Prospective Study
    Ueki, Masaru
    Koda, Masahiko
    Shimizu, Tatsunori
    Mitsuta, Akeri
    Yamamoto, Tetsuo
    Murawaki, Yoshikazu
    HEPATO-GASTROENTEROLOGY, 2009, 56 (93) : 1100 - 1104
12345